期刊文献+

加味健脾解毒方抗小鼠腹水肝癌恶液质模型的机制研究 被引量:7

Effect and Mechanisms of Modified Jianpi Jiedu Recipe on Cachexia of Ascites Hepatoma Mice
下载PDF
导出
摘要 目的:探索加味健脾解毒方对腹水型肝癌小鼠恶病质及IL-1a、IL-6、TNF-a和泛素蛋白酶体途径的作用。方法:60只C57BL/6小鼠随机分为正常对照组,荷瘤模型组,中药低浓度组、中药高浓度组、醋酸甲羟孕酮联合吲哚美辛组5组。H22肝癌细胞株腹腔注射建立小鼠腹水型肝癌恶病质模型,记录小鼠体质量、摄食量、腓肠肌重量等恶液质指标;检测腹水IL-1a、IL-6、TNF-a水平;检测腓肠肌Mu-RF1、Atrogin1蛋白及mRNA表达。结果:与模型组比,高、低浓度加味健脾解毒方明显减缓小鼠体质量及腹水增长(P<0.05),降低小鼠腓肠肌消耗(P<0.01),提高去腹水体质量(P<0.01)和摄食量(P<0.05);降低腹水IL-1a、IL-6、TNF-a水平(P<0.01);降低Mu-RF1、Atrogin1蛋白及mRNA表达(P<0.01)。上述指标高浓度中药优于低浓度中药(P<0.05);高浓度中药与醋酸甲羟孕酮联合吲哚美辛组相当(P>0.05)。腹水量和肝脏指数高浓度中药优于醋酸甲羟孕酮联合吲哚美辛组(P<0.05)。结论:加味健脾解毒方可延缓腹水肝癌小鼠的恶病质进展,可能与其降低IL-1、IL-6、TNF-a水平及抑制泛素蛋白酶体途径过度激活有关。 Objective: To explore the effect of modified Jianpi Jiedu Recipe( MJPJD) on cachexia of ascites hepatoma mice and IL-1a,IL-6,TNF-α and ubiquitin proteasome pathways. Methods: 60 C57 BL /6 mice were randomly divided into normal control group,tumor model group,MJPJD low and high concentrations groups and medroxyprogesterone acetate combined with indomethacin group. Mice cachexia model was established by intraperitoneal injection of H22 hepatoma cell line. We recorded cachexia conditions such as body weight,food intake,gastrocnemius weight and so on. ELISA was used to detect IL-1a,IL-6 and TNF-α levels in ascites. Western Blot and RT-PCR detected protein and mRNA of Mu-RF1 and Atrogin1 in mice gastrocnemius muscle. Results: Compared with model group,the high and low concentrations of MJPJD groups can effectively control the body weight and growth of mice ascites( P 〈0. 05),decrease mice gastrocnemius muscle consumption significantly( P〈 0. 01),maintain the net weight( P 〈0. 01),increase the food intake of mice( P 〈0. 05) and can significantly lower the levels of IL-1a,IL-6 and TNF-α( P〈 0. 01) and significantly reduce the Mu-RF1,Atrogin1 protein and mRNA expressions( P 〈0. 01). These indexes above of high concentration MJPJD group were better than that of low concentration MJPJD group( P 〈0. 05) and similar to medroxyprogesterone acetate combined with indomethacin group( P〈 0. 05). Ascites weight and liver index of high concentration MJPJD group were better than that of medroxyprogesterone acetate combined with indomethacin group( P〉 0. 05). Conclusion: The modified Jianpi Jiedu Recipe might delay the cachexia progress of cachexia of liver cancer ascites mice model and its mechanism is associated with reducing IL-1,IL-6 and TNF-α levels and the inhibition of the over activation of ubiquitin proteasome pathway.
出处 《中华中医药学刊》 CAS 北大核心 2015年第12期2830-2835,I0018-I0020,共9页 Chinese Archives of Traditional Chinese Medicine
基金 国家自然科学基金青年科学基金项目(81102581)
关键词 健脾解毒方 肝癌 恶病质 Mu-RF1 Atrogin1. Jianpi Jiedu Recipe liver cancer Cachexia Mu-RF1 Atrogin1
  • 相关文献

参考文献18

  • 1Kenneth Fearon,Florian Strasser,Stefan D Anker,et al.Definition and classification of cancer cachexia:an international consensus[J].Lancet Oncol,2011,12:489-495. 被引量:1
  • 2Mondello P,Mian M,Aloisi C,et al.Cancer cachexia syndrome:pathogenesis,diagnosis,and new therapeutic options[J].Nutr Cancer,2015,67(1):12-26. 被引量:1
  • 3Wallengren O,Lundholm K,Bosaeus I.Diagnostic criteria of cancer cachexia:relation to quality of life,exercise capacity and survival in unselected palliative care patients[M].Support Care Cancer,2013,21(6):1569-1577. 被引量:1
  • 4Von Haehling S,Anker SD.Treatment of Cachexia:An Overview of Recent Developments[J].J Am Med Dir Assoc,2014,15(12):866-872. 被引量:1
  • 5Radbruch L,Elsner F,Trottenberg P,et al.Clinical practice guidelines on cancer cachexia in advanced cancer patients[J].Aachen:Department of Palliative Medicine/European Palliative Care Research Collaborative,2010. 被引量:1
  • 6Li-Rong Yin,Ze-Xiong Chen,Shi-Jun Zhang,Bao-Guo Sun,Yong-Dong Liu,Hong-Zhong Huang.Expression of phosphatase and tensin homolog deleted on chromosome ten in liver of athymic mice with hepatocellular carcinoma and the effect of Fuzheng Jiedu Decoction[J].World Journal of Gastroenterology,2008,14(1):108-113. 被引量:10
  • 7孙保国,陈泽雄,周厚明,张诗军,黄红中.解毒法与健脾法对裸鼠人肝癌模型的持续抗癌作用探讨[J].中华中医药学刊,2010,28(8):1666-1670. 被引量:5
  • 8Esper DH,Harb WA.The cancer cachexia syndrome:a review of metabolic and clinical manifestations[J].Nutr Clin Pract,2005,20(4):369-376. 被引量:1
  • 9Gullett NP,Hebbar G,Ziegler TR.Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting[J].Am J Clin Nutr,2010,91(4):1143-1147. 被引量:1
  • 10Diament MJ,Peluffo GD,Stillitani I,et al.Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin[J].Cancer Invest,2006,24:126-131. 被引量:1

二级参考文献18

共引文献11

同被引文献126

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部